Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
AMGN
AMGN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
AMGN News
Market Momentum Broadens Beyond AI
2d ago
CNBC
SpaceX Stock Soars, Tesla Deliveries Exceed Expectations
3d ago
CNBC
Amgen Rated Among High Yield Fortune 500 Stocks
5d ago
Yahoo Finance
Future Outlook for Obesity Drugs Market
6d ago
CNBC
Future Outlook for Obesity Medications
6d ago
Newsfilter
AbbVie Showcases New Data in Blood Cancer Portfolio
Jun 12 2026
Fool
AbbVie Expands Blood Cancer Treatment Market with New Data
Jun 12 2026
NASDAQ.COM
Amgen Re-evaluates Tavneos Data Amid FDA Concerns
Jun 11 2026
seekingalpha
Amgen Rated Among Most Profitable Dividend Stocks
Jun 09 2026
Yahoo Finance
Amgen Reports Positive VESALIUS-CV Trial Results for Repatha
Jun 08 2026
NASDAQ.COM
Repatha Significantly Reduces Cardiovascular Event Risk in High-Risk Diabetes Patients
Jun 07 2026
Newsfilter
Repatha® Reduces Major Cardiovascular Events by 29% in High-Risk Diabetes Patients
Jun 07 2026
Yahoo Finance
Repatha® Significantly Reduces Cardiovascular Event Risk in High-Risk Diabetes Patients
Jun 07 2026
PRnewswire
Recommended High-Yield ETF: Schwab U.S. Dividend Equity ETF
Jun 06 2026
Fool
Analysis of Schwab U.S. Dividend Equity ETF
Jun 06 2026
NASDAQ.COM
Exploring Investment Opportunities in Amgen
Jun 06 2026
Fool
Show More News
